Association between cancer chemotherapy and canine distemper virus, canine parvovirus, and rabies virus antibody titers in tumor-bearing dogs
Authors:
- Dudley L. McCawDMDudley L. McCaw
- Kenny V. BrockKBKenny V. Brock
- Aaron M. StokerASAaron M. Stoker
- Jeff W. TylerJTJeff W. Tyler
- Deborah J. TateDTDeborah J. Tate
- Mary Lynn HigginbothamMHMary Lynn Higginbotham
- 1 November 2001
- journal article
- Published by American Veterinary Medical Association (AVMA) in Journal of the American Veterinary Medical Association
- Vol. 219 (9) , 1238-1241
Abstract
Objective—To determine the association between cancer chemotherapy and serum canine distemper virus (CDV), canine parvovirus (CPV), and rabies virus antibody titers in tumor-bearing dogs. Design—Prospective study. Animals—21 client-owned dogs with various malignancies and 16 client-owned dogs with lymphoma. Procedure—In study A, serum antibody titers were measured by use of hemagglutination inhibition (CPV titers) or serum neutralization (CDV titers) before and at least 1 month after initiation of chemotherapy. Baseline values were compared with values obtained from a control population of 122 healthy dogs seen for routine revaccination. Titers were considered protective at ≥ 1:96 for CDV and ≥ 1:80 for CPV. In study B, serum IgG titers were measured by use of immunofluorescent assay (CDV and CPV titers) and rapid fluorescent focus inhibition test (RFFIT, rabies titers) at baseline and again at weeks 5, 8, and 24 of a standard chemotherapy protocol for treatment of lymphoma. An IgG titer of ≥ 1:50 was considered protective for CPV and CDV. An RFFIT titer of ≥ 0.5 U/ml was considered protective for rabies virus. Results—Significant changes were not detected in CDV, CPV, and rabies virus titers following chemotherapy in tumor-bearing dogs. Conclusions and Clinical Relevance—Results suggest that established immunity to CDV, CPV, and rabies virus from previous vaccination is not significantly compromised by standard chemotherapy used to treat tumor-bearing dogs. (J Am Vet Med Assoc 2001;219:1238–1241)Keywords
This publication has 11 references indexed in Scilit:
- Impaired response to hepatitis B vaccine in children receiving anticancer chemotherapyThe Pediatric Infectious Disease Journal, 1995
- Critical Appraisal of Immunization Strategies for Prevention of Infection in the Compromised HostHematology/Oncology Clinics of North America, 1993
- Antibody response to a two-dose influenza vaccine regimen in adult lymphoma patients on chemotherapyEuropean Journal of Clinical Microbiology & Infectious Diseases, 1993
- Active Immunization of Children with Leukemia and Other MalignanciesLeukemia & Lymphoma, 1993
- Impaired primary antibody responses after vaccination against hepatitis B in patients with breast cancerBreast Cancer Research and Treatment, 1992
- Measles and rubella antibody status in previously vaccinated children with cancerMedical and Pediatric Oncology, 1988
- Secretory antibodies in IgA-deficient and immunosuppressed individualsJournal of Clinical Immunology, 1986
- Hepatitis B virus markers in children with acute leukemia: The effect of chemotherapyJournal of Medical Virology, 1985
- Varicella in Children With Cancer: Seventy-Seven CasePediatrics, 1975
- Immune Reactivity in Dogs With Spontaneous Malignancy 2 3JNCI: Journal of the National Cancer Institute, 1974